RT Journal Article
SR Electronic
A1 Vinall, Phil
T1 Results at 1 Year with CoreValve TAVR in Patients with Symptomatic Aortic Stenosis
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 24
SP 20
OP 21
DO 10.1177/155989771424014
UL http://mdc.sagepub.com/content/14/24/20.abstract
AB Transcatheter aortic valve replacement (TAVR) has become a treatment option for patients with severe aortic stenosis who either are not surgical candidates or are at high risk for surgical complications. The results from the US CoreValve pivotal trials support the safety and efficacy of the CoreValve prosthesis in these patient populations. This article discusses detailed data from the CoreValve trials